12 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
of the treatments or any event already present that worsens in either intensity or frequency following exposure to the treatments TYK Tyrosine kinase
6-K
EX-99.2
GLPG
Galapagos NV
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
Emergent Adverse Event, is any event not present prior to the initiation of the treatments or any event already present that worsens in either intensity
6-K
EX-99.2
GLPG
Galapagos NV
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
Treatment Emergent or any event Adverse already Event, present is any that event worsens not inpresent either intensity prior to or the frequency initiation
6-K
EX-99.2
GLPG
Galapagos NV
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
not inpresent either intensity prior to orthe frequency initiation following of the exposure to the treatments
TYK
residues Tyrosine of kinase
6-K
EX-99.2
xdjelg6yeqe01i0vg7
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
mvhwit
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.2
aw1o62w1 59
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.2
j4qlln9lynz
11 May 21
Current report (foreign)
2:10pm
- Prev
- 1
- Next